Video

How Adherence Is Measured

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about how medication adherence is measured.

David Nau, PhD, RPh, FAPhA, president of Pharmacy Quality Solutions, talks about how medication adherence is measured.

This video was recorded at APhA's 2015 annual meeting in San Diego, California.

Related Videos
Related Content
Sleepless, man suffering from insomnia, sleep apnea or stress. Tired and exhausted guy. Headache or migraine. Awake in the night.
December 20th 2024

FDA Approves Tirzepatide as First Treatment for Moderate-to-Severe Obstructive Sleep Apnea in Adults With Obesity

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

Varicella zoster or chickenpox virus, ai illustration. A herpes virus which cause chickenpox and shingles - Image credit: Cristina | stock.adobe.com
December 20th 2024

Study: Fatal Disseminated Herpes Zoster in Immunocompetent Individuals

Kennedy Ferruggia, Assistant Editor
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
Mounjaro tirzepatide GLP-1 receptor agonist vial | Image Credit: © Cynthia - stock.adobe.com
December 20th 2024

FDA Affirms Decision on Tirzepatide Shortage Resolved, Sets Transition Period for Compounding

Alexandra Gerlach, Associate Editor
Women With History of Gestational Diabetes Found to Have Less Inflammatory Diets
December 20th 2024

Women With History of Gestational Diabetes Found to Have Less Inflammatory Diets

Aislinn Antrim, Assistant Managing Editor